Search Page

1

Biomanufacturing for clinically advanced cell therapies.

Aijaz A, Li M, Smith D, Khong D, LeBlon C, Fenton OS, Olabisi RM, Libutti S, Tischfield J, Maus MV, Deans R, Barcia RN, Anderson DG, Ritz J, Preti R, Parekkadan B. Aijaz A, et al. Nat Biomed Eng. 2018 Jun;2(6):362-376. doi: 10.1038/s41551-018-0246-6. Epub 2018 Jun 11. Nat Biomed Eng. 2018. PMID: 31011198 Free PMC article. Review.

Cite

Share

2

The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation.

Knoblich K, Cruz Migoni S, Siew SM, Jinks E, Kaul B, Jeffery HC, Baker AT, Suliman M, Vrzalikova K, Mehenna H, Murray PG, Barone F, Oo YH, Newsome PN, Hirschfield G, Kelly D, Lee SP, Parekkadan B, Turley SJ, Fletcher AL. Knoblich K, et al. PLoS Biol. 2018 Sep 4;16(9):e2005046. doi: 10.1371/journal.pbio.2005046. eCollection 2018 Sep. PLoS Biol. 2018. PMID: 30180168 Free PMC article.

Cite

Share

3

Kinetics of MSC-based enzyme therapy for immunoregulation.

Burr A, Parekkadan B. Burr A, et al. J Transl Med. 2019 Aug 13;17(1):263. doi: 10.1186/s12967-019-2000-6. J Transl Med. 2019. PMID: 31409424 Free PMC article.

Cite

Share

4

Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression.

Li M, Chin LY, Shukor S, Tamayo AG, Maus MV, Parekkadan B. Li M, et al. Autoimmunity. 2019 May;52(3):102-107. doi: 10.1080/08916934.2019.1630064. Epub 2019 Jun 25. Autoimmunity. 2019. PMID: 31238751

Cite

Share

5

Stromalized microreactor supports murine hematopoietic progenitor enrichment.

Khong D, Li M, Singleton A, Chin LY, Parekkadan B. Khong D, et al. Biomed Microdevices. 2018 Jan 20;20(1):13. doi: 10.1007/s10544-017-0255-3. Biomed Microdevices. 2018. PMID: 29353324 Free PMC article.

Cite

Share

6

Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model.

Mukundan S, Sharma K, Honselmann K, Singleton A, Liss A, Parekkadan B. Mukundan S, et al. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818803632. doi: 10.1177/1533033818803632. Technol Cancer Res Treat. 2018. PMID: 30348057 Free PMC article.

Cite

Share

7

Artificial T Cell Mimetics to Combat Melanoma Tumor Growth.

Mukundan S, Guan D, Singleton A, Yang Y, Li M, Parekkadan B. Mukundan S, et al. Am J Adv Drug Deliv. 2018;6(1):21-32. Am J Adv Drug Deliv. 2018. PMID: 30197907 Free PMC article.

Cite

Share

8

Convergence of Cell Pharmacology and Drug Delivery.

Aijaz A, Vaninov N, Allen A, Barcia RN, Parekkadan B. Aijaz A, et al. Stem Cells Transl Med. 2019 Sep;8(9):874-879. doi: 10.1002/sctm.19-0019. Epub 2019 May 15. Stem Cells Transl Med. 2019. PMID: 31091020 Free PMC article.

Cite

Share

9

Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction.

Li M, Khong D, Chin LY, Singleton A, Parekkadan B. Li M, et al. Sci Rep. 2018 May 1;8(1):6816. doi: 10.1038/s41598-018-24971-2. Sci Rep. 2018. PMID: 29717209 Free PMC article.

Cite

Share

10

Orthogonal potency analysis of mesenchymal stromal cell function during ex vivo expansion.

Khong D, Li M, Singleton A, Chin LY, Mukundan S, Parekkadan B. Khong D, et al. Exp Cell Res. 2018 Jan 1;362(1):102-110. doi: 10.1016/j.yexcr.2017.11.007. Epub 2017 Nov 11. Exp Cell Res. 2018. PMID: 29137914 Free PMC article.

Cite

Share